Nightrage A New Disease Is Bornrar Review

By 2050, a prototype serum was developed, but at a cost: patients had to undergo luminal therapy , a grueling process involving daily exposure to synthetic starlight. Though effective, the therapy could only be administered in controlled environments. Meanwhile, isolated outbreaks still emerge in remote regions, where the disease’s nocturnal dread lingers. Today, Nightrage is a cautionary tale. The World Health Organization lists it as a Tier 1 biohazard, and NexGen Solutions was dismantled under public outrage. Dr. Voss vanished in 2048, leaving behind a ledger of unethical experiments.